Researchers add to evidence suggesting that inflammatory factors contribute to increased risk for valvular heart diseases, such as aortic stenosis, in patients with rheumatoid arthritis.
Patients with rheumatoid arthritis (RA) were found to have an increased risk for developing aortic stenosis (AS), according to a study published in JAMA Internal Medicine.
The multitude of inflammatory factors brought on by RA has been affiliated with higher risk of cardiovascular disease (CVD). On top of this, CVD is the top contributing factor to mortality in patients with RA.
The authors note that patients with RA endure a 75% increased rate of death at the hands of valvular heart disease. The most common cause of valvular heart disease–related death, and the reason most associated with valve replacement, is AS. Although many past studies have correlated RA with forms of CVD, AS has yet to be sufficiently evaluated.
Given that a patient with RA’s vulnerability to developing AS is unknown, the researchers conducted a matched-cohort study to assess the risk of AS-related outcomes—such as aortic valve intervention—and disease development in these individuals.
Data were gathered between January 1, 2000, and December 31, 2019, from the national Veterans Health Administration (VHA) and CMS databases. Patients identified with RA were matched with up to 10 patients without RA (controls) according to age, sex, and year of enrollment in the virtual databases. Individuals were excluded if they had a history of aortic valve intervention or AS, and all were followed until the earliest AS outcome, end of the study period, or death.
AS risk factors were measured with test results for RA-related autoantibodies (rheumatoid factor [RF] and anti-cyclic citrullinated protein [anti-CCP]), erythrocyte sedimentation rates (ESR), and C-reactive protein (CRP) levels. Primary outcomes included AS incidence (official diagnosis, record of related death, or aortic valve intervention); secondary outcomes were concerned with the individual interventions that took place and AS-related death outcomes.
In total, 73,070 patients with RA were identified alongside 639,268 controls. By the end of the study period, 16,109 composite AS outcomes were registered that spanned 6,223,150 person-years. Of these, 2303 events were experienced by patients with RA.
The mean age of RA incidence between the RA group and controls were fairly similar (74.9 vs 75.5 years, respectively). For every 1000 person-years, having RA resulted in a 1.52-fold risk increase for AS-related events: 3.97 (95% CI, 3.81-4.13) vs 2.45 (95% CI, 2.41-2.49). Additionally, RA was associated with higher rates of composite AS (adjusted HR [aHR], 1.48; 95% CI, 1.41-1.55), aortic valve intervention (aHR, 1.34; 95% CI, 1.22-1.48), and AS-related death (aHR, 1.26; 95% CI, 1.04-1.54).
At baseline, 68.9% of patients with RA registered seropositive tests for RF or anti-CPP, and 47% had elevated CRP or ESR levels. In the authors’ results, these elevated levels and/or a seronegative test were linked with higher risk of developing AS. They found this important to note; however, they mentioned that these factors were not statistically significant in the outcomes.
The researchers’ findings aligned with those of previous RA cohorts that demonstrated these patients carried higher risks for developing other forms of CVD, such as ischemic heart disease. Their study further confirms the RA-CVD association and highlights that “valvular heart disease, specifically AS, may be an overlooked CVD complication in RA.”
While their research confirmed the increased risks carried by patients with RA, the authors concluded by expressing the need for further research on this matter to verify the role of conditions like AS in the CVD-related complications that coincide with RA.
Reference
Johnson TM, Mahabir CA, Yang Y, et al. Aortic stenosis risk in rheumatoid arthritis. JAMA Intern Med. 2023;183(9):973-981. doi:10.1001/jamainternmed.2023.3087
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Initiating BP Medication Linked to Higher Fall, Fracture Risks in Nursing Home Residents
May 2nd 2024Among over 60,000 nursing home residents who initiated antihypertensive medication, rates of excess fractures due to falls per 100 person-years were as high as 5 among certain patient groups, such as those with dementia and high blood pressure (BP).
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen